[go: up one dir, main page]

CN106565444A - Extraction method and application of phenanthrene compounds from overground part of Chinese yam - Google Patents

Extraction method and application of phenanthrene compounds from overground part of Chinese yam Download PDF

Info

Publication number
CN106565444A
CN106565444A CN201610906423.9A CN201610906423A CN106565444A CN 106565444 A CN106565444 A CN 106565444A CN 201610906423 A CN201610906423 A CN 201610906423A CN 106565444 A CN106565444 A CN 106565444A
Authority
CN
China
Prior art keywords
compound
ethanol
jing
volume ratio
yam
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201610906423.9A
Other languages
Chinese (zh)
Other versions
CN106565444B (en
Inventor
张来宾
吕洁丽
刘军伟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xinxiang Medical University
Original Assignee
Xinxiang Medical University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xinxiang Medical University filed Critical Xinxiang Medical University
Priority to CN201610906423.9A priority Critical patent/CN106565444B/en
Publication of CN106565444A publication Critical patent/CN106565444A/en
Application granted granted Critical
Publication of CN106565444B publication Critical patent/CN106565444B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C46/00Preparation of quinones
    • C07C46/10Separation; Purification; Stabilisation; Use of additives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01Preparation of ethers
    • C07C41/34Separation; Purification; Stabilisation; Use of additives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01Preparation of ethers
    • C07C41/34Separation; Purification; Stabilisation; Use of additives
    • C07C41/36Separation; Purification; Stabilisation; Use of additives by solid-liquid treatment; by chemisorption
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/20Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/23Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C50/00Quinones
    • C07C50/26Quinones containing groups having oxygen atoms singly bound to carbon atoms
    • C07C50/34Quinones containing groups having oxygen atoms singly bound to carbon atoms the quinoid structure being part of a condensed ring system having three rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

本发明公开了一种山药地上部分菲类化合物的提取方法及应用,属于山药地上部分有效成分的分离及应用技术领域。本发明的技术方案要点为:山药地上部分粗粉用乙醇渗漉提取并浓缩,提取物用有机溶剂萃取,然后经大孔吸附树脂、硅胶、葡聚糖糖凝胶等柱层析分离得到菲类化合物。本发明的山药地上部分提取的四种菲类化合物对a‑葡萄糖苷酶均有显著的抑制活性,在相同条件下均强于降血糖药阿卡波糖的活性。

The invention discloses an extraction method and application of phenanthrene compounds in the aerial part of yam and belongs to the technical field of separation and application of effective components in the aerial part of yam. The key points of the technical scheme of the present invention are: the coarse powder of the aboveground part of yam is extracted and concentrated by ethanol percolation, the extract is extracted with an organic solvent, and then separated by column chromatography such as macroporous adsorption resin, silica gel, dextran sugar gel, etc. to obtain phenanthrene class of compounds. The four phenanthrene compounds extracted from the aerial part of the yam of the present invention all have significant inhibitory activity on a-glucosidase, and are stronger than the activity of the hypoglycemic drug acarbose under the same conditions.

Description

山药地上部分菲类化合物的提取方法及应用Extraction method and application of phenanthrene compounds in aerial parts of yam

技术领域technical field

本发明属于山药地上部分有效成分的分离及应用技术领域,具体涉及一种山药地上部分菲类化合物的提取方法及应用。The invention belongs to the technical field of separation and application of effective components in aerial parts of yams, and in particular relates to an extraction method and application of phenanthrene compounds in aerial parts of yams.

背景技术Background technique

由于人民生活水平的提高、饮食结构的改变以及少动多坐的生活方式等诸多因素,全球糖尿病发病率增长迅速,糖尿病已经成为继肿瘤、心血管病变之后第三大严重威胁人类健康的慢性疾病。糖尿病的发病过程中最先出现的症状往往是餐后高血糖,即糖尿病的早期征兆,特别是Ⅱ型糖尿病病人,餐后高血糖不仅极易诱发各种并发症,还会极大地提高糖尿病的死亡率。所以,降低餐后血糖是预防糖尿病、减少并发症和降低死亡率的重要措施之一。α-葡萄糖苷酶是碳水化合物消化过程的一种关键酶,它可将多糖或二糖水解成为能够供人体吸收的单糖,因此抑制α-葡萄糖苷酶的活性就能延缓食物中碳水化合物的分解,从而减少葡萄糖的摄入,达到抑制餐后血糖升高的目的。目前临床上的此类药物有阿卡波糖、伏格列波糖和米格列醇。现有的α-葡萄糖苷酶抑制剂种类较少,并伴有肠道副作用,因此人们仍不断致力于开发新型α-葡萄糖苷酶抑制剂。Due to many factors such as the improvement of people's living standards, changes in diet structure, and less active and more sedentary lifestyle, the incidence of diabetes worldwide has increased rapidly. Diabetes has become the third chronic disease that seriously threatens human health after tumors and cardiovascular diseases. . The first symptom in the pathogenesis of diabetes is often postprandial hyperglycemia, which is the early sign of diabetes, especially for patients with type Ⅱ diabetes. Postprandial hyperglycemia not only easily induces various complications, but also greatly increases the risk of diabetes. mortality rate. Therefore, reducing postprandial blood sugar is one of the important measures to prevent diabetes, reduce complications and reduce mortality. α-glucosidase is a key enzyme in the carbohydrate digestion process. It can hydrolyze polysaccharides or disaccharides into monosaccharides that can be absorbed by the human body. Therefore, inhibiting the activity of α-glucosidase can delay the digestion of carbohydrates in food. Decomposition, thereby reducing the intake of glucose, to achieve the purpose of inhibiting postprandial blood sugar rise. Currently clinical drugs of this type include acarbose, voglibose, and miglitol. There are few kinds of α-glucosidase inhibitors available and they are accompanied by intestinal side effects, so people are still working on the development of new α-glucosidase inhibitors.

山药(Disocorea opposita Thunb.)为薯蓣科薯蓣的干燥根茎,具有补脾养肺,固肾益精之功效,临床上广泛用于治疗消渴症、慢性腹泻和虚劳咳嗽等症状,是我国传统的药食同源中药之一,自古以河南焦作(古怀庆府)所产最为地道,故称“怀山药”,为著名的“四大怀药”之一。2006年河南省武陟县获批山药GAP种植基地,解决了野生山药资源短缺,资源可持续利用发展等问题。山药以地下根茎入药,地上部分常作为废弃物被遗弃,导致资源的极大浪费。目前对于山药的研究主要集中于地下根茎(入药部位)的研究,药理研究显示其具有降血糖、降血脂、抗氧化和抗肿瘤等活性。然而对于山药地上部分的研究非常少,未见其在降血糖方面的研究报道。Yam ( Disocorea opposita Thunb.) is the dry rhizome of Dioscorea yam, which has the effects of nourishing the spleen and lungs, strengthening the kidney and benefiting the essence. It is widely used clinically to treat symptoms such as diabetes, chronic diarrhea and consumptive cough. It is one of the traditional Chinese medicines with the same source of medicine and food. Since ancient times, Jiaozuo, Henan (ancient Huaiqing Prefecture) is the most authentic, so it is called "Huaiyam", and it is one of the famous "Four Huaiyao". In 2006, Wuzhi County, Henan Province was approved as a yam GAP planting base, which solved the shortage of wild yam resources and the sustainable utilization and development of resources. Chinese yam uses underground rhizomes as medicine, and the aboveground parts are often discarded as waste, resulting in a great waste of resources. At present, the research on yam mainly focuses on the underground rhizome (medicinal part), pharmacological studies have shown that it has hypoglycemic, hypolipidemic, antioxidative and antitumor activities. However, there are very few studies on the aerial part of yam, and there is no research report on its ability to lower blood sugar.

发明内容Contents of the invention

本发明解决的技术问题是提供了一种山药地上部分菲类化合物的提取方法及应用。The technical problem to be solved by the present invention is to provide an extraction method and application of phenanthrene compounds in the aerial part of yam.

本发明为解决上述技术问题采用如下技术方案,山药地上部分菲类化合物的提取方法,其特征在于具体步骤为:The present invention adopts following technical scheme for solving the above-mentioned technical problem, the extracting method of phenanthrene compound of yam aerial part, is characterized in that concrete steps are:

(1)将阴干的山药地上部分粉碎后,用体积分数为90%-95%的乙醇渗漉提取,合并提取液,减压浓缩得到山药地上部分乙醇提取物,再将该乙醇提取物悬浮于蒸馏水中,依次用石油醚和乙酸乙酯萃取,收集乙酸乙酯萃取液并减压浓缩得到乙酸乙酯萃取物,将乙酸乙酯萃取物经大孔吸附树脂柱层析,依次用体积分数为60%的乙醇、体积分数为80%的乙醇和体积分数为95%的乙醇洗脱,收集体积分数为80%的乙醇洗脱液和体积分数为95%的乙醇洗脱液分别减压浓缩得到80%乙醇洗脱产物和95%乙醇洗脱产物;(1) After crushing the above-ground part of yam dried in the shade, extract by percolation with ethanol with a volume fraction of 90%-95%, combine the extracts, concentrate under reduced pressure to obtain the ethanol extract of the above-ground part of yam, and then suspend the ethanol extract in In distilled water, extract with petroleum ether and ethyl acetate successively, collect the ethyl acetate extract and concentrate under reduced pressure to obtain the ethyl acetate extract, the ethyl acetate extract is subjected to macroporous adsorption resin column chromatography, and the volume fraction is 60% ethanol, ethanol with a volume fraction of 80% and ethanol with a volume fraction of 95% were eluted, and the ethanol eluate with a volume fraction of 80% and the ethanol eluate with a volume fraction of 95% were concentrated under reduced pressure to obtain 80% ethanol elution product and 95% ethanol elution product;

(2)将80%乙醇洗脱产物经常压硅胶柱层析,用石油醚-丙酮溶剂系统在体积比为5:1-1:1的范围内和二氯甲烷-甲醇溶剂系统在体积比为2:1-1:1的范围内梯度洗脱,经TLC鉴定合并相同组分得到初始目标组分,将初始目标组分经常压硅胶柱层析,用二氯甲烷-丙酮溶剂系统在体积比为50:1-10:1的范围内梯度洗脱分别得到化合物1、化合物4和中间目标组分,再将中间目标组分重结晶得到化合物2,其中化合物1的结构式为,化合物2的结构式为,化合物4的结构式为(2) The product eluted with 80% ethanol is subjected to normal pressure silica gel column chromatography, and the petroleum ether-acetone solvent system is used in the volume ratio of 5:1-1:1 and the methylene chloride-methanol solvent system is used in the volume ratio of Gradient elution within the range of 2:1-1:1, identified by TLC and combined with the same components to obtain the initial target component, the initial target component was subjected to normal pressure silica gel column chromatography, and dichloromethane-acetone solvent system was used in volume ratio Gradient elution in the range of 50:1-10:1 respectively obtains compound 1, compound 4 and intermediate target components, and then recrystallizes the intermediate target components to obtain compound 2, wherein the structural formula of compound 1 is , the structural formula of compound 2 is , the structural formula of compound 4 is ;

(3)将95%乙醇洗脱产物经常压硅胶柱层析,用石油醚-丙酮溶剂系统在体积比为5:1-1:1的范围内和二氯甲烷-甲醇溶剂系统在体积比为2:1-1:1的范围内梯度洗脱,经TLC鉴定合并相同组分得到初始目标组分,将初始目标组分经常压硅胶柱层析,用二氯甲烷-丙酮溶剂系统在体积比为100:0-20:1的范围内梯度洗脱,经TLC鉴定合并相同组分得到中间目标组分,中间目标组分经葡聚糖凝胶柱色谱和半制备HPLC纯化得到化合物3,该化合物3的结构式为,其中葡聚糖凝胶柱色谱的洗脱液为甲醇,半制备HPLC的流动相为体积比75:25的甲醇-水混合溶液。(3) The product eluted with 95% ethanol is subjected to normal pressure silica gel column chromatography, and the petroleum ether-acetone solvent system is used in the volume ratio of 5:1-1:1 and the dichloromethane-methanol solvent system is in the volume ratio of Gradient elution within the range of 2:1-1:1, identified by TLC and combined with the same components to obtain the initial target component, the initial target component was subjected to normal pressure silica gel column chromatography, and dichloromethane-acetone solvent system was used in volume ratio Gradient elution in the range of 100:0-20:1, identified by TLC and combined with the same components to obtain the intermediate target component, the intermediate target component was purified by Sephadex column chromatography and semi-preparative HPLC to obtain compound 3, the The structural formula of compound 3 is , wherein the eluent of Sephadex column chromatography is methanol, and the mobile phase of semi-preparative HPLC is a methanol-water mixed solution with a volume ratio of 75:25.

进一步优选,所述的大孔吸附树脂为Diaion HP-20型大孔吸附树脂,葡聚糖凝胶为Sephadex LH-20型葡聚糖凝胶。Further preferably, the macroporous adsorption resin is Diaion HP-20 type macroporous adsorption resin, and the dextran gel is Sephadex LH-20 type dextran gel.

根据上述方法提取的山药地上部分菲类化合物在制备降血糖药物或保健品中的应用。Application of the phenanthrene compounds from the aerial parts of yam extracted according to the above method in the preparation of hypoglycemic drugs or health care products.

根据上述方法提取的山药地上部分菲类化合物在制备α-葡萄糖苷酶抑制剂类药物或保健品中的应用。Application of the aerial part phenanthrene compounds of Chinese yam extracted according to the above method in the preparation of α-glucosidase inhibitor drugs or health care products.

根据上述方法提取的化合物4在制备α-葡萄糖苷酶抑制剂类药物或保健品中的应用。Application of compound 4 extracted according to the above method in the preparation of α-glucosidase inhibitor drugs or health care products.

本发明通过体外α-葡萄糖苷酶抑制活性研究发现山药地上部分提取的四种菲类化合物对α-葡萄糖苷酶均有显著的抑制作用,其IC50分别为3.04±0.25mM、0.49±0.034mM、4.13±0.023mM和0.07±0.0031mM,明显强于阳性对照药阿卡波糖的活性(IC50为61.57±1.40mM),并且对α-葡萄糖苷酶的抑制率均呈剂量依赖性。In the present invention, through research on the inhibitory activity of α-glucosidase in vitro, it is found that the four phenanthrene compounds extracted from the aerial part of Chinese yam all have significant inhibitory effects on α-glucosidase, and their IC50 are 3.04±0.25mM and 0.49±0.034mM respectively , 4.13±0.023mM and 0.07±0.0031mM, significantly stronger than the activity of the positive control drug acarbose (IC 50 is 61.57±1.40mM), and the inhibition rate of α-glucosidase is dose-dependent.

附图说明Description of drawings

图1是实施例1提取的化合物1对α-葡萄糖苷酶抑制率随药物浓度的变化曲线;Fig. 1 is the variation curve of the compound 1 that embodiment 1 extracts to α-glucosidase inhibitory rate with drug concentration;

图2是实施例2提取的化合物2对α-葡萄糖苷酶抑制率随药物浓度的变化曲线;Fig. 2 is the compound 2 that embodiment 2 extracts to the change curve of α-glucosidase inhibitory rate with drug concentration;

图3是实施例3提取的化合物3对α-葡萄糖苷酶抑制率随药物浓度的变化曲线;Fig. 3 is the variation curve of the compound 3 that embodiment 3 extracts to α-glucosidase inhibitory rate with drug concentration;

图4是实施例1提取的化合物4对α-葡萄糖苷酶抑制率随药物浓度的变化曲线。Fig. 4 is the variation curve of compound 4 extracted in Example 1 on the inhibitory rate of α-glucosidase with drug concentration.

具体实施方式detailed description

以下通过实施例对本发明的上述内容做进一步详细说明,但不应该将此理解为本发明上述主题的范围仅限于以下的实施例,凡基于本发明上述内容实现的技术均属于本发明的范围。The above-mentioned contents of the present invention are described in further detail below through the embodiments, but this should not be interpreted as the scope of the above-mentioned themes of the present invention being limited to the following embodiments, and all technologies realized based on the above-mentioned contents of the present invention all belong to the scope of the present invention.

实施例1Example 1

阴干的山药地上部分8.5kg,粉碎后,用体积分数为95%的乙醇渗漉提取,合并提取液,减压浓缩得总浸膏871.5g,将浸膏悬浮于2倍量水中,依次用5倍量的石油醚和乙酸乙酯萃取,收集乙酸乙酯萃取液并减压浓缩,得到乙酸乙酯萃取物100.2g。将乙酸乙酯萃取物经Diaion HP-20型大孔吸附树脂柱层析,依次用体积分数为60%的乙醇和体积分数为80%的乙醇洗脱,收集体积分数为80%的乙醇洗脱液并减压浓缩,得到80%乙醇洗脱产物45.7g。80%乙醇洗脱产物经常压硅胶柱层析,用石油醚-丙酮(体积比分别为5:1、3:1、2:1和1:1)和二氯甲烷-甲醇(体积比分别为2:1和1:1)溶剂系统洗脱,经TLC鉴定合并相同组分得到10个组分(Fr.1-Fr.10)。Fr.4经常压硅胶柱层析,用二氯甲烷-丙酮(体积比分别为50:1、30:1、20:1和10:1)溶剂系统洗脱,分别得到化合物1(2.6mg)和化合物4(2.1mg)。Shade-dried 8.5kg of aerial part of yam, crushed, extracted by percolation with ethanol with a volume fraction of 95%, combined the extracts, concentrated under reduced pressure to obtain 871.5g of total extract, suspended the extract in 2 times the amount of water, and washed with 5 Double the amount of petroleum ether and ethyl acetate for extraction, the ethyl acetate extract was collected and concentrated under reduced pressure to obtain 100.2 g of ethyl acetate extract. The ethyl acetate extract was subjected to Diaion HP-20 type macroporous adsorption resin column chromatography, eluted with 60% ethanol and 80% ethanol in sequence, and collected 80% ethanol for elution. liquid and concentrated under reduced pressure to obtain 45.7 g of 80% ethanol-eluted product. The product was eluted with 80% ethanol and subjected to normal pressure silica gel column chromatography, using petroleum ether-acetone (volume ratios of 5:1, 3:1, 2:1 and 1:1) and dichloromethane-methanol (volume ratios of 2:1 and 1:1) solvent system elution, identified by TLC and combined the same components to obtain 10 components (Fr.1-Fr.10). Fr.4 Normal pressure silica gel column chromatography, eluting with dichloromethane-acetone (50:1, 30:1, 20:1 and 10:1 by volume) solvent system, respectively, to obtain compound 1 (2.6mg) and compound 4 (2.1 mg).

化合物1和4的波谱数据:7-hydroxy-2,6-dimethoxy-1,4-phenanthrenedione(1):红色无定形粉末,ESI-MS m/z307 [M+Na]+1H-NMR (400 MHz, DMSO-d 6) δ: 10.35(1H, s, 7-OH), 9.01 (1H, s, H-5), 8.03 (1H, d, J = 8.5 Hz, H-10), 7.87 (1H,d, J = 8.5 Hz, H-9), 7.26 (1H, s, H-8), 6.24 (1H, s, H-3), 3.96 (3H, s, 6-OCH3), 3.86 (3H, s, 2-OCH3); 13C-NMR (400 MHz, DMSO-d 6) δ: 188.6 (C-4), 180.5(C-1), 158.4 (C-2), 152.5 (C-6), 149.6 (C-7), 134.4 (C-8a), 131.7 (C-9),128.7 (C-10a), 124.9 (C-4b), 124.8 (C-4a), 120.0 (C-10), 111.3 (C-3), 110.3(C-8), 106.1 (C-5), 56.4 (2-OCH3), 55.5 (6-OCH3)。Spectral data of compounds 1 and 4: 7-hydroxy-2,6-dimethoxy-1,4-phenanthrenedione (1): red amorphous powder, ESI-MS m/z 307 [M+Na] + . 1 H-NMR (400 MHz, DMSO- d 6 ) δ: 10.35(1H, s, 7-OH), 9.01 (1H, s, H-5), 8.03 (1H, d, J = 8.5 Hz, H- 10), 7.87 (1H,d, J = 8.5 Hz, H-9), 7.26 (1H, s, H-8), 6.24 (1H, s, H-3), 3.96 (3H, s, 6-OCH 3 ), 3.86 (3H, s, 2-OCH 3 ); 13 C-NMR (400 MHz, DMSO- d 6 ) δ: 188.6 (C-4), 180.5(C-1), 158.4 (C-2) , 152.5 (C-6), 149.6 (C-7), 134.4 (C-8a), 131.7 (C-9), 128.7 (C-10a), 124.9 (C-4b), 124.8 (C-4a), 120.0 (C-10), 111.3 (C-3), 110.3 (C-8), 106.1 (C-5), 56.4 (2-OCH 3 ), 55.5 (6-OCH 3 ).

volucrin (4):淡黄色无定形粉末,HRESI-MS m/z 561.1520 [M+Na]+ (calcdfor C32H26O8Na, 561.1525。1H-NMR (400 MHz, acetone-d 6) δ: 9.28 (2H, s, H-5, 5'),7.29 (2H, d, J = 9.1 Hz, H-10, 10'), 6.99 (2H, d, J = 9.1 Hz, H-9, 9'), 6.92(2H, d, J = 2.5 Hz, H-1, 1'), 6.81 (2H, d, J = 2.5 Hz, H-3, 3'), 4.16 (6H, s,4,4¢-OCH3), 3.90 (6H, s, 2,2¢-OCH3)。 Volucrin (4): Pale yellow amorphous powder, HRESI-MS m/z 561.1520 [M+Na] + (calcdfor C 32 H 26 O 8 Na, 561.1525. 1 H-NMR (400 MHz, acetone- d 6 ) δ : 9.28 (2H, s, H-5, 5'),7.29 (2H, d, J = 9.1 Hz, H-10, 10'), 6.99 (2H, d, J = 9.1 Hz, H-9, 9 '), 6.92(2H, d, J = 2.5 Hz, H-1, 1'), 6.81 (2H, d, J = 2.5 Hz, H-3, 3'), 4.16 (6H, s,4,4 ¢-OCH 3 ), 3.90 (6H, s, 2,2¢-OCH 3 ).

实施例2Example 2

阴干的山药地上部分8.5kg,粉碎后,用体积分数为95%的乙醇渗漉提取,合并提取液,减压浓缩得总浸膏871.5g,将浸膏悬浮于2倍量水中,依次用5倍量的石油醚和乙酸乙酯萃取,收集乙酸乙酯萃取液并减压浓缩,得到乙酸乙酯萃取物100.2g。将乙酸乙酯萃取物经Diaion HP-20型大孔吸附树脂柱层析,依次用体积分数为60%的乙醇和体积分数为80%的乙醇洗脱,收集体积分数为80%的乙醇洗脱液并减压浓缩,得到80%乙醇洗脱产物45.7g。80%乙醇洗脱产物经常压硅胶柱层析,用石油醚-丙酮(体积比分别为5:1、3:1、2:1和1:1)和二氯甲烷-甲醇(体积比分别为2:1和1:1)溶剂系统洗脱,经TLC鉴定合并相同组分得到10个组分(Fr.1-Fr.10)。Fr.8重结晶得到化合物2(7.0mg)。Shade-dried 8.5kg of aerial part of yam, crushed, extracted by percolation with ethanol with a volume fraction of 95%, combined the extracts, concentrated under reduced pressure to obtain 871.5g of total extract, suspended the extract in 2 times the amount of water, and washed with 5 Double the amount of petroleum ether and ethyl acetate for extraction, the ethyl acetate extract was collected and concentrated under reduced pressure to obtain 100.2 g of ethyl acetate extract. The ethyl acetate extract was subjected to Diaion HP-20 type macroporous adsorption resin column chromatography, eluted with 60% ethanol and 80% ethanol in sequence, and collected 80% ethanol for elution. liquid and concentrated under reduced pressure to obtain 45.7 g of 80% ethanol-eluted product. The product was eluted with 80% ethanol and subjected to normal pressure silica gel column chromatography, using petroleum ether-acetone (volume ratios of 5:1, 3:1, 2:1 and 1:1) and dichloromethane-methanol (volume ratios of 2:1 and 1:1) solvent system elution, identified by TLC and combined the same components to obtain 10 components (Fr.1-Fr.10). Fr.8 was recrystallized to give Compound 2 (7.0 mg).

化合物2的波谱数据:6,7-dihydroxy-2-methoxy-1,4-phenanthrenedione (2):红色无定形粉末,ESI-MS m/z 293 [M+Na]+1H-NMR (400 MHz, DMSO-d 6) δ: 8.93 (1H,s, H-5), 7.95 (1H, d, J = 8.4Hz, H-9), 7.78 (1H, d, J = 8.4Hz, H-10), 7.20(1H, s, H-8), 6.21 (1H, s, H-3), 3.84 (3H, s, 2-OCH3)。Spectrum data of compound 2: 6,7-dihydroxy-2-methoxy-1,4-phenanthrenedione (2): red amorphous powder, ESI-MS m/z 293 [M+Na] + . 1 H-NMR (400 MHz, DMSO- d 6 ) δ: 8.93 (1H, s, H-5), 7.95 (1H, d, J = 8.4Hz, H-9), 7.78 (1H, d, J = 8.4Hz, H-10), 7.20(1H, s, H-8), 6.21 (1H, s, H-3), 3.84 (3H, s, 2-OCH 3 ).

实施例3Example 3

阴干的山药地上部分8.5kg,粉碎后,用体积分数为95%的乙醇渗漉提取,合并提取液,减压浓缩得总浸膏871.5g,将浸膏悬浮于2倍量水中,依次用5倍量的石油醚和乙酸乙酯萃取,收集乙酸乙酯萃取液并减压浓缩,得到乙酸乙酯萃取物100.2g。将乙酸乙酯萃取物经Diaion HP-20型大孔吸附树脂柱层析,依次用体积分数为80%的乙醇和体积分数为95%的乙醇洗脱,收集体积分数为95%的乙醇洗脱液并减压浓缩,得到95%乙醇洗脱产物25.0g。95%乙醇洗脱产物经常压硅胶柱层析,用石油醚-丙酮(体积比分别为5:1、3:1、2:1和1:1)和二氯甲烷-甲醇(体积比分别为2:1和1:1)溶剂系统洗脱,经TLC鉴定合并相同组分得到7个组分(Fr.1-Fr.7)。Fr.2经常压硅胶柱层析,用二氯甲烷-丙酮(体积比分别为100:0、50:1和20:1)溶剂系统洗脱,经TLC鉴定合并相同组分得到6个组分 (Fr.2.1-Fr.2.6),Fr.2.6经Sephadex LH-20葡聚糖凝胶柱色谱(甲醇洗脱)和半制备HPLC(流动相:甲醇-水,体积比75:25)纯化得到化合物3(2.4mg)。Shade-dried 8.5kg of aerial part of yam, crushed, extracted by percolation with ethanol with a volume fraction of 95%, combined the extracts, concentrated under reduced pressure to obtain 871.5g of total extract, suspended the extract in 2 times the amount of water, and washed with 5 Double the amount of petroleum ether and ethyl acetate for extraction, the ethyl acetate extract was collected and concentrated under reduced pressure to obtain 100.2 g of ethyl acetate extract. The ethyl acetate extract was subjected to Diaion HP-20 type macroporous adsorption resin column chromatography, eluted with 80% ethanol and 95% ethanol in sequence, and collected 95% ethanol for elution. liquid and concentrated under reduced pressure to obtain 25.0 g of 95% ethanol-eluted product. The product was eluted with 95% ethanol and subjected to normal pressure silica gel column chromatography, using petroleum ether-acetone (volume ratios of 5:1, 3:1, 2:1 and 1:1) and dichloromethane-methanol (volume ratios of 2:1 and 1:1) solvent system elution, identified by TLC and combining the same components to obtain 7 components (Fr.1-Fr.7). Fr.2 Normal pressure silica gel column chromatography, eluted with dichloromethane-acetone (100:0, 50:1 and 20:1 by volume ratio) solvent system, identified by TLC and combined the same components to obtain 6 components (Fr.2.1-Fr.2.6), Fr.2.6 was purified by Sephadex LH-20 Sephadex column chromatography (elution with methanol) and semi-preparative HPLC (mobile phase: methanol-water, volume ratio 75:25) Compound 3 (2.4 mg).

化合物3的波谱数据:7-hydroxy-2,4,6-trimethoxyphenanthrene (3):白色粉末,ESI-MS m/z307 [M+Na]+1H-NMR (400 MHz, acetone-d 6) δ: 9.04 (1H, s, H-5),7.66 (1H, d, J = 8.8 Hz, H-9), 7.52 (1H, d, J = 8.8 Hz, H-10), 7.37 (1H, s,H-8), 6.98 (1H, d, J = 2.5 Hz, H-1), 6.78 (1H, d, J = 2.5 Hz, H-3), 4.11 (3H,s, 2-OCH3), 3.99 (3H, s, 6-OCH3), 3.92 (3H, s, 4-OCH3); 13C-NMR (100 MHz,acetone-d 6) δ: 160.4 (C-2), 158.7 (C-4), 147.6 (C-6), 147.3 (C-7), 135.9 (C-10a), 128.6 (C-9), 127.7 (C-4b), 126.5 (C-8a), 125.2 (C-10), 116.2 (C-4a),113.5 (C-8), 109.2 (C-5), 102.2 (C-1), 99.7 (C-3), 56.1 (6, 4-OCH3), 55.7 (2-OCH3)。Spectrum data of compound 3: 7-hydroxy-2,4,6-trimethoxyphenanthrene (3): white powder, ESI-MS m/z 307 [M+Na] + . 1 H-NMR (400 MHz, acetone- d 6 ) δ: 9.04 (1H, s, H-5), 7.66 (1H, d, J = 8.8 Hz, H-9), 7.52 (1H, d, J = 8.8 Hz, H-10), 7.37 (1H, s, H-8), 6.98 (1H, d, J = 2.5 Hz, H-1), 6.78 (1H, d, J = 2.5 Hz, H-3) , 4.11 (3H,s, 2-OCH 3 ), 3.99 (3H, s, 6-OCH 3 ), 3.92 (3H, s, 4-OCH 3 ); 13 C-NMR (100 MHz,acetone- d 6 ) δ: 160.4 (C-2), 158.7 (C-4), 147.6 (C-6), 147.3 (C-7), 135.9 (C-10a), 128.6 (C-9), 127.7 (C-4b) , 126.5 (C-8a), 125.2 (C-10), 116.2 (C-4a), 113.5 (C-8), 109.2 (C-5), 102.2 (C-1), 99.7 (C-3), 56.1 (6, 4-OCH 3 ), 55.7 (2-OCH 3 ).

实施例4Example 4

本实施例为上述实施例提取的化合物1-4对α-葡萄糖苷酶的抑制活性测试。This example is a test of the inhibitory activity of compounds 1-4 extracted from the above examples on α-glucosidase.

方法:微孔板法。Method: microplate method.

仪器:酶标仪,恒温培养箱,分析天平,各种型号移液枪。Instruments: microplate reader, constant temperature incubator, analytical balance, various types of pipette guns.

试剂:α-葡萄糖苷酶、4-硝基苯-α-D-吡喃葡萄糖苷、阿卡波糖、磷酸盐缓冲液和二甲基亚砜。Reagents: α-glucosidase, 4-nitrophenyl-α-D-glucopyranoside, acarbose, phosphate buffer, and dimethylsulfoxide.

测试方法:取96孔板,每孔加入2.0mmol/L的PNPG溶液(PBS溶解)80μL,再分别加入10μL不同浓度样品溶液(DMSO溶解),以DMSO为空白对照组,每组设3个平行孔,在酶标仪400nm下测定背景组吸光度(A值)。然后再加入10μL 1.62U/mL α-葡萄糖苷酶溶液(PBS溶解),置于恒温培养箱中,在37℃下恒温孵育30min,测定试验组吸光度(A值)。抑制率(%)用以下公式计算:Test method: Take a 96-well plate, add 80 μL of 2.0 mmol/L PNPG solution (dissolved in PBS) to each well, and then add 10 μL of sample solutions of different concentrations (dissolved in DMSO), use DMSO as the blank control group, and set 3 parallels in each group Wells, the absorbance (A value) of the background group was measured at 400 nm in a microplate reader. Then add 10 μL 1.62U/mL α-glucosidase solution (dissolved in PBS), place in a constant temperature incubator, and incubate at 37°C for 30 minutes, and measure the absorbance (A value) of the test group. Inhibition rate (%) was calculated with the following formula:

抑制率(%)= (ΔA空白-ΔA样品)/ΔA空白×100%Inhibition rate (%) = (ΔA blank - ΔA sample ) / ΔA blank × 100%

ΔA空白为空白组酶与底物反应后A值-背景A值;ΔA blank is the A value after the blank group enzyme reacts with the substrate - the background A value;

ΔA样品为样品组酶与底物反应后A值-背景A值。ΔA sample is the A value after the reaction of the sample group enzyme with the substrate - the background A value.

化合物1-4对α-葡萄糖苷酶的抑制活性结果如下(表1):The results of the inhibitory activity of compounds 1-4 on α-glucosidase are as follows (Table 1):

表1 化合物1-4对α-葡萄糖苷酶的抑制活性Table 1 Inhibitory activity of compounds 1-4 on α-glucosidase

化合物compound IC50(mM) IC50 (mM) 11 3.04± 0.253.04±0.25 22 0.49± 0.0340.49±0.034 33 4.13± 0.0234.13±0.023 44 0.07± 0.00310.07±0.0031 阿卡波糖Acarbose 61.57±1.4061.57±1.40

从表1可以看出,实施例1-3提取的化合物1-4对α-葡萄糖苷酶的抑制活性均强于阳性对照药阿卡波糖的活性,其中化合物4的活性最强,远优于阳性对照药阿卡波糖的活性。As can be seen from Table 1, the inhibitory activity of compounds 1-4 extracted in Examples 1-3 to α-glucosidase is stronger than that of the positive control drug acarbose, and the activity of compound 4 is the strongest, far superior to The activity of the positive control drug acarbose.

以上实施例描述了本发明的基本原理、主要特征及优点,本行业的技术人员应该了解,本发明不受上述实施例的限制,上述实施例和说明书中描述的只是说明本发明的原理,在不脱离本发明原理的范围下,本发明还会有各种变化和改进,这些变化和改进均落入本发明保护的范围内。The above embodiments have described the basic principles, main features and advantages of the present invention. Those skilled in the art should understand that the present invention is not limited by the above embodiments. What are described in the above embodiments and description are only to illustrate the principles of the present invention. Without departing from the scope of the principle of the present invention, there will be various changes and improvements in the present invention, and these changes and improvements all fall within the protection scope of the present invention.

Claims (5)

1. the extracting method of Rhizoma Dioscoreae aerial partss phenanthrene class compound, it is characterised in that concretely comprise the following steps:
(1)After the Rhizoma Dioscoreae aerial partss for drying in the shade are crushed, with the ethanol percolate extraction that volume fraction is 90%-95%, united extraction Liquid, is concentrated under reduced pressure to give Rhizoma Dioscoreae aerial partss ethanol extraction, then the ethanol extraction is suspended in distilled water, use stone successively Oily ether and ethyl acetate extraction, collect acetic acid ethyl acetate extract and are concentrated under reduced pressure to give acetic acid ethyl ester extract, by ethyl acetate Extract Jing macroporous adsorbent resin column chromatographies, successively with the ethanol that volume fraction is 60%, the ethanol that volume fraction is 80% and body Fraction is 95% ethanol elution, the ethanol elution that collected volume fraction is 80% ethanol elution and volume fraction is 95% Liquid is concentrated under reduced pressure to give 80% ethanol elution product and 95% ethanol elution product respectively;
(2)By 80% ethanol elution product Jing normal pressure silica gel columns chromatograph, with petroleum ether-acetone solvent system volume ratio be 5:1- 1:In the range of 1 and methylene chloride-methanol solvent system volume ratio be 2:1-1:Gradient elution in the range of 1, Jing TLC identifications Merge same composition and obtain initial target component, initial target component Jing normal pressure silica gel column is chromatographed, it is molten with dichloromethane-acetone Agent system is 50 in volume ratio:1-10:In the range of 1, gradient elution respectively obtains compound 1, compound 4 and intermediate objective group Point, then intermediate objective component is recrystallized to give into compound 2, the structural formula of wherein compound 1 is, The structural formula of compound 2 is, the structural formula of compound 4 is
(3)By 95% ethanol elution product Jing normal pressure silica gel columns chromatograph, with petroleum ether-acetone solvent system volume ratio be 5:1- 1:In the range of 1 and methylene chloride-methanol solvent system volume ratio be 2:1-1:Gradient elution in the range of 1, Jing TLC identifications Merge same composition and obtain initial target component, initial target component Jing normal pressure silica gel column is chromatographed, it is molten with dichloromethane-acetone Agent system is 100 in volume ratio:0-20:Gradient elution in the range of 1, Jing TLC identifications merge same composition and obtain intermediate objective Component, intermediate objective component Jing dextran gel column chromatography and half preparation HPLC purification obtain compound 3, the knot of the compound 3 Structure formula is, the wherein eluent of dextran gel column chromatography is methanol, and half prepares HPLC Mobile phase be volume ratio 75:25 methanol-water mixed solution.
2. the extracting method of Rhizoma Dioscoreae aerial partss according to claim 1 phenanthrene class compound, it is characterised in that:Described is big Macroporous adsorbent resin be Diaion HP-20 type macroporous adsorbent resins, polydextran gel be Sephadex LH-20 types glucosan coagulate Glue.
3. the Rhizoma Dioscoreae aerial partss phenanthrene class compound that the method described in claim 1 or 2 is extracted is preparing hypoglycemic drug or guarantor Application in strong product.
4. the Rhizoma Dioscoreae aerial partss phenanthrene class compound that the method described in claim 1 or 2 is extracted is preparing alpha-glucosidase suppression Application in preparation class medicine or health product.
5. the compound 4 that the method described in claim 1 or 2 is extracted is preparing alpha-glucosidase inhibitor medicine or health care Application in product.
CN201610906423.9A 2016-10-18 2016-10-18 The extracting method and application of Chinese yam aerial part phenanthrene class compound Active CN106565444B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610906423.9A CN106565444B (en) 2016-10-18 2016-10-18 The extracting method and application of Chinese yam aerial part phenanthrene class compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610906423.9A CN106565444B (en) 2016-10-18 2016-10-18 The extracting method and application of Chinese yam aerial part phenanthrene class compound

Publications (2)

Publication Number Publication Date
CN106565444A true CN106565444A (en) 2017-04-19
CN106565444B CN106565444B (en) 2019-03-19

Family

ID=58533623

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610906423.9A Active CN106565444B (en) 2016-10-18 2016-10-18 The extracting method and application of Chinese yam aerial part phenanthrene class compound

Country Status (1)

Country Link
CN (1) CN106565444B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108440258A (en) * 2018-04-10 2018-08-24 南阳师范学院 The extracting method and its medical application of new luxuriant and rich with fragrance class compound in ground slightly melon
CN110742271A (en) * 2019-10-30 2020-02-04 广东省农业科学院蚕业与农产品加工研究所 Application of yam active component as gastrointestinal mucosa injury improver and application thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104292081A (en) * 2014-03-07 2015-01-21 河南大学 Method for extracting batatasin from plant Chinese yam

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104292081A (en) * 2014-03-07 2015-01-21 河南大学 Method for extracting batatasin from plant Chinese yam

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
LIN ZHANG等: "a-Glucosidase inhibitors from Chinese Yam (Dioscorea opposita Thunb.)", 《FOOD CHEMISTRY》 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108440258A (en) * 2018-04-10 2018-08-24 南阳师范学院 The extracting method and its medical application of new luxuriant and rich with fragrance class compound in ground slightly melon
CN108440258B (en) * 2018-04-10 2019-10-15 南阳师范学院 Extraction method and medical application of phenanthrene compounds in sweet potato
CN110742271A (en) * 2019-10-30 2020-02-04 广东省农业科学院蚕业与农产品加工研究所 Application of yam active component as gastrointestinal mucosa injury improver and application thereof
CN110742271B (en) * 2019-10-30 2022-06-14 广东省农业科学院蚕业与农产品加工研究所 Use and application of active components of Chinese yam in the preparation of intestinal mucosal injury improving agent

Also Published As

Publication number Publication date
CN106565444B (en) 2019-03-19

Similar Documents

Publication Publication Date Title
Juan-Badaturuge et al. Antioxidant compounds from a South Asian beverage and medicinal plant, Cassia auriculata
CN102153534B (en) Compound with tyrosinase inhibitory activity as well as preparation method and application thereof
Motta et al. Galloylquinic acid derivatives from Copaifera langsdorffii leaves display gastroprotective activity
CN102924421B (en) Preparation method and application of compound having tyrosinase inhibitory activity
CN117736140B (en) A pyridine alkaloid compound in purslane and its extraction and separation method and use
Wang et al. New α-glucosidase inhibitors with p-terphenyl skeleton from the mushroom Hydnellum concrescens
CN108774276B (en) Viburnum sargentii fruit lignan extract and active ingredient and application thereof
CN106727598B (en) Preparation method of broad-leaved fenghuacao triterpenoids and its application in the preparation of glycosidase inhibitor drugs
CN118164933B (en) Furan new compound in purslane, and extraction and separation method and application thereof
Wei-Yan et al. New arbutin derivatives from the leaves of Heliciopsis lobata with cytotoxicity
CN106565444A (en) Extraction method and application of phenanthrene compounds from overground part of Chinese yam
CN106518629A (en) Active component of liquorice leaf and structure and application thereof
CN102161649A (en) Polyphenol type derivatives extracted from mulberry leaves and preparation method and applications thereof
CN109796511B (en) A kind of new iridoid compound and its preparation method and medical use
CN111548255B (en) Diterpenoids in Douglas fir and its preparation method and use in pharmacy
CN113004299B (en) Xanthone compound in mangosteen bark for reducing postprandial blood sugar, and extraction method and application thereof
CN106565811B (en) The extracting method of the hypoglycemic active ingredient of Chinese yam aerial part and application
CN103239435B (en) Preparation method of gynura divaricata total caffeoylquinic acid and application in antihyperglycemic agent or health-care product
CN114456191B (en) Extraction method and application of tocopherol derivatives of overground parts of Chinese yam
CN109897079B (en) A kind of preparation method and application of coumarin glycoside compound
CN102826982A (en) Monoterpene compounds prepared from Senecio cannabifolius Less, and extraction method and application thereof
CN103641882B (en) Novel 2,3-dihydroxyl-30-noroleanolic acid as well as preparation method and application thereof in preparing glycosidase inhibitor medicament
CN103739660B (en) A kind of compound, its extracting method, its application preparing antitumor drug and antitumor drug of preparation thereof
CN103083342B (en) Use of flavanoids in the preparation of anti-complement drugs
CN118165054B (en) Pyran new compound in purslane, and extraction and separation method and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant